据悉，2024欧美恶性肿瘤调查行业协会（AACR）年终晚会在欧美禁地亚哥偏远地区时光4月10日落下帷幕谢幕，集萃ob电竞官网入口
在每一次电视电话会议上展览了7张广告图，带来了列席者的强烈座谈会。
集萃ob电竞官网入口
展示的海报内容涵盖免疫重建小鼠模型、Enhertu耐药肿瘤模型、治疗性抗体的临床前评估、HER2靶向药物、IL-12临床前药物研发、人源化抗体领域小鼠模型、临床前PD-1耐药模型这7项研究成果：
01 Preclinical PD-1 Resistance Models: Crucial Tools for Unveiling PD-1 Resistance Mechanisms and Advancing Novel Treatment Strategies
02 NeoMab™: A Novel Platform for Fully Human Therapeutic Antibody Development
03 Patient-derived xenograft (PDX) models with differential HER2 expression for preclinical evaluation of HER2-targeted therapies
04 Development of a Novel Murine Model, NCG-M/hIL15, for Enhanced Post-HSC Transplantation Immunoreconstruction
05 Development and Application of the NCG-hIL2 Mouse Model: A Humanized Platform for Enhanced NK Cell Evaluation in ADCC Efficacy Testing
06 BALB/c-hIL12RB1/hIL12RB2: A Robust Model for Preclinical Research in Human IL-12 Therapy
07 Breaking Through ADCs Resistance: Constructing Preclinical Enhertu-induced Resistant Model
您可双击下侧下载安装链接下载安装集萃ob电竞官网入口
AACR 2024海报图：
